← Back to Search

Behavioral Intervention

Patient Priorities Care for Dementia (IN-TX-PPC Trial)

N/A
Recruiting
Led By Jennifer L Carnahan, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months pre and 2 months post baseline
Awards & highlights

IN-TX-PPC Trial Summary

This trial will evaluate if Patient Priorities Care, a conversation that identifies and prioritizes patient goals, can improve health outcomes for those living with dementia or mild cognitive impairment.

Who is the study for?
This trial is for English-speaking patients at Indiana sites or English/Spanish speakers in Texas, aged 40+, with mild cognitive impairment or dementia. They must be treated by a participating doctor and have an outpatient visit scheduled within two months.Check my eligibility
What is being tested?
The study tests Patient Priorities Care (PPC) in primary care and geriatrics clinics. It involves identifying eligible patients using health records, engaging them in PPC conversations about their priorities, and measuring outcomes like days at home.See study design
What are the potential side effects?
Since this trial focuses on conversation-based intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from discussing their priorities.

IN-TX-PPC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months pre and 2 months post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months pre and 2 months post baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients with documentation of Patient Priorities Care discussion in the electronic health record
Secondary outcome measures
Acceptability
Appropriateness
Feasibility of the intervention using Proctor et al as a guide
+6 more

IN-TX-PPC Trial Design

1Treatment groups
Experimental Treatment
Group I: Patient Priorities Care Eligible Persons Living With Dementia and Mild Cognitive ImpairmentExperimental Treatment1 Intervention
Patients (and their care partners when available) will receive a packet of information about Patient Priorities Care, and when feasible, a trained facilitator(s) will initiate a Patient Priorities Care conversation with the patient or patient care partner dyad. This conversation will be documented in the Electronic Health Record.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Priorities Care
2016
N/A
~420

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,690 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,725 Total Patients Enrolled
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,602 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available in this research endeavor?

"Affirmative. The information available on clinicaltrials.gov indicates that the trial, first posted on August 31st 2023 is currently enrolling patients. 160 participants need to be acquired from a single medical centre."

Answered by AI

How many individuals are engaged in this investigation?

"Affirmative. As per the information on clinicaltrials.gov, this medical trial is still actively enrolling candidates; it was initially posted on August 31st 2023 and adjusted most recently on September 6th of the same year. Currently 160 volunteers are required to partake in testing at 1 site."

Answered by AI
~18 spots leftby Jun 2024